In an earlier filing to the bourses on March 9, the drug firm had said it had received five observations from the US Food and Drug Administration (USFDA) for its API Hyderabad plant 3 at Medak district.from Moneycontrol Business News https://ift.tt/2tJRTN6
Comments
Post a Comment